Conference Coverage
Conference Coverage
EXPECT: Omalizumab pregnancy safety data called ‘reassuring’
Key clinical point: Omalizumab does not appear to increase the risk of birth defects or adverse outcomes in pregnant women and their babies.
Conference Coverage
Tips for managing pregnant patients with migraine
Conference Coverage
Aromatase inhibitors linked to cardiovascular disease
Key clinical point: Breast cancer patients who take an adjuvant aromatase inhibitor have a higher risk of new-onset nonischemic cardiovascular...
Conference Coverage
Trendelenburg positioning does not increase ventilator injuries
Key clinical point: Gynecologic surgeons and anesthesiologists should negotiate to reduce pneumoperitoneum pressure instead of the degree of...
Conference Coverage
International study characterizes male breast cancer
Key clinical point: Male breast cancers are similar to female cancers in terms of tumor characteristics and long-term outcomes. Major finding:...
Conference Coverage
Hopkins protocol aims to limit sarcoma morcellation risk
Key clinical point: In addition to the FDA’s recent morcellation contraindications, the procedure shouldn’t be done in women who have uterine...
Conference Coverage
Consider biopsy for active lupus nephritis in pregnancy
Conference Coverage
Recommendations mixed on oral contraceptives for female migraineurs
Conference Coverage
Randomized trial assesses behavioral weight loss as migraine treatment
Conference Coverage
Expert panel endorses continued use of morcellation
Conference Coverage
Battle over morcellation lost ‘in the media’
Key clinical point: Relevant Google searches rose sharply as the debate unfolded. Major finding: The mean monthly number of searches for “...